Aerie Pharmaceuticals Inc

MORGAN STANLEY

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

1,319,893

Value ($000)

19,969

Weight

0.0%

2013 Q4 - 2022 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	19,969	0.0%	1,319,893	9/30/2022
2022 Q2	10/27/2022	14,934	0.0%	1,991,084	6/30/2022
2022 Q1	10/27/2022	28,647	0.0%	3,148,069	3/31/2022
2021 Q4	2/14/2022	28,302	0.0%	4,031,555	12/31/2021
2021 Q3	11/15/2021	25,310	0.0%	2,220,236	9/30/2021
2021 Q2	8/23/2021	29,853	0.0%	1,864,630	6/30/2021
2021 Q1	5/17/2021	31,157	0.0%	1,743,482	3/31/2021
2020 Q4	2/16/2021	23,622	0.0%	1,748,448	12/31/2020
2020 Q3	11/13/2020	17,421	0.0%	1,480,168	9/30/2020
2020 Q2	8/14/2020	18,242	0.0%	1,235,961	6/30/2020
2020 Q1	5/26/2020	9,788	0.0%	725,107	3/31/2020
2019 Q4	2/14/2020	20,100	0.0%	831,619	12/31/2019
2014 Q1	5/13/2014	105	0.0%	4,964	3/31/2014
2013 Q4	2/13/2014	400	0.0%	22,338	12/31/2013